Zobrazeno 1 - 10
of 319
pro vyhledávání: '"Lipika Goyal"'
Autor:
Lipika Goyal, Smitha Krishnamurthi, Dung T Le, Ronan J Kelly, Cathy Eng, Geoffrey Ku, Manish A Shah, Marwan Fakih, Joseph Chao, Van K Morris, Katherine Bever, Kristen K Ciombor, Joleen Hubbard, Renuka Iyer, Holly T Kemberling, Mindy Mintz Mordecai, Andrew Scott Paulson, Valerie Peterson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Gastrointestinal (GI) cancers, including esophageal, gastroesophageal junction, gastric, duodenal and distal small bowel, biliary tract, pancreatic, colon, rectal, and anal cancer, comprise a heterogeneous group of malignancies that impose a signific
Externí odkaz:
https://doaj.org/article/ebebf3bf4cc94f57adb8f23cda6cee23
Autor:
David Goldstein, Richard Hubner, Angela Lamarca, Lipika Goyal, Junji Furuse, Tanios Bekaii-Saab, Jennifer Knox, Mairéad G McNamara, Juan Valle, Rachna Shroff, Chigusa Morizane, Lorenza Rimassa, John Bridgewater, Timothy Jacobs, Anna D Wagner, Markus Moehler, Maeve Lowery, Robin K Kelley
Publikováno v:
BMJ Open, Vol 12, Iss 10 (2022)
Objectives Female physicians in medicine are increasing, but disparities in female authorship exist. The aim of this study was to characterise factors associated with female first (FF) and female senior (SF) authorship in later phase systemic oncolog
Externí odkaz:
https://doaj.org/article/01c4ef9a216d47869af0aedf52dbfa7c
Autor:
Bernard Pereira, Christopher T. Chen, Lipika Goyal, Charlotte Walmsley, Christopher J. Pinto, Islam Baiev, Read Allen, Laura Henderson, Supriya Saha, Stephanie Reyes, Martin S. Taylor, Donna M. Fitzgerald, Maida Williams Broudo, Avinash Sahu, Xin Gao, Wendy Winckler, A. Rose Brannon, Jeffrey A. Engelman, Rebecca Leary, James R. Stone, Catarina D. Campbell, Dejan Juric
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
It is currently unclear if cell-free DNA samples from metastatic cancers are as informative as tissue ones for cancer profiling. Here the authors show that cell-free DNA samples from rapid autopsies capture clonal and subclonal alterations of metasta
Externí odkaz:
https://doaj.org/article/a702ab2e73e84ce88013c89389a381ef
Autor:
Amaia Lujambio, Thomas Yau, Lipika Goyal, Andrew X Zhu, Ignacio Melero, Tim F Greten, Ann-Lii Cheng, Bruno Sangro, David J Pinato, Peter R Galle, Ghassan K Abou-Alfa, Austin G Duffy, Anthony B. El-Khoueiry, Richard S Finn, Aiwu Ruth He, Ahmed O Kaseb, Robin Kate Kelley, Riccardo Lencioni, Donna Mabry Hrones, Roberto I Troisi, Andrea Wilson Woods
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Patients with advanced hepatocellular carcinoma (HCC) have historically had few options and faced extremely poor prognoses if their disease progressed after standard-of-care tyrosine kinase inhibitors (TKIs). Recently, the standard of care for HCC ha
Externí odkaz:
https://doaj.org/article/c395a80c692945e793e9d243958829ae
Autor:
Lipika Goyal, Mark Cobbold, Rakesh K Jain, Ivy X Chen, Ayako Shigeta, Daniel Staiculescu, Dieter Zopf, Lukas Fiebig, Gabriela S Hobbs, Peigen Huang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background and purpose Combining inhibitors of vascular endothelial growth factor and the programmed cell death protein 1 (PD1) pathway has shown efficacy in multiple cancers, but the disease-specific and agent-specific mechanisms of benefit remain u
Externí odkaz:
https://doaj.org/article/3a16c10d09a0429d990a0dd5f6981ee3
Autor:
Sophia C. Kamran, Jeffrey W. Clark, Hui Zheng, Darrell R. Borger, Lawrence S. Blaszkowsky, Jill N. Allen, Eunice L. Kwak, Jennifer Y. Wo, Aparna R. Parikh, Ryan D. Nipp, Janet E. Murphy, Lipika Goyal, Andrew X. Zhu, A. John Iafrate, Ryan B. Corcoran, David P. Ryan, Theodore S. Hong
Publikováno v:
Cancer Medicine, Vol 7, Iss 7, Pp 2934-2942 (2018)
Abstract Recent reports demonstrate inferior outcomes associated with primary right‐sided vs left‐sided colorectal tumors in patients with metastatic colorectal cancer (mCRC). We sought to describe our experience with mCRC patients on whom we hav
Externí odkaz:
https://doaj.org/article/d8d818ceb29849aab15f3fbceae5ca4e
Autor:
Rahmi Oklu, Rahul Sheth, Hassan Albadawi, Irun Bhan, A. Fatih Sarioglu, Melissa Choz, Mahnaz Zeinali, Vikram Deshpande, Shyamala Maheswaran, Daniel A. Haber, Shannon L. Stott, Andrew X. Zhu, Lipika Goyal, Mehmet Toner, David T. Ting
Publikováno v:
Cancer Convergence, Vol 2, Iss 1, Pp 1-9 (2018)
Abstract Background Microfluidic platforms have demonstrated the ability to isolate rare circulating tumor cells from a wide variety of cancers. Our group has recently shown the ability to isolate circulating tumor cells (CTCs) from hepatocellular ca
Externí odkaz:
https://doaj.org/article/02fc3077978f47c28212257b691d0e91
Autor:
Kimberly Perez, Anna M Chiarella, James M Cleary, Nora Horick, Colin Weekes, Thomas Abrams, Lawrence Blaszkowsky, Peter Enzinger, Marios Giannakis, Lipika Goyal, Jeffrey A Meyerhardt, Douglas Rubinson, Matthew B Yurgelun, Wolfram Goessling, Bruce J Giantonio, Lauren Brais, Victoria Germon, Danielle Stonely, Srivatsan Raghavan, Basil Bakir, Koushik Das, Jason R Pitarresi, Andrew J Aguirre, Michael Needle, Anil K Rustgi, Brian M Wolpin
Publikováno v:
The Oncologist. 28:425-432
Background In preclinical pancreatic ductal adenocarcinoma (PDAC) models, inhibition of hepatocyte growth factor (HGF) signaling using ficlatuzumab, a recombinant humanized anti-HGF antibody, and gemcitabine reduced tumor burden. Methods Patients wit
Autor:
Surendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, Aparna Govindan, Lei Zhao, Jay Luther, Irun Bhan, Emily Bethea, Joseph W Franses, Elizabeth Paige Walsh, Leigh Anne Dageford, Shoko Kimura, Nahel Elias, Heidi Yeh, James Markman, Adel Bozorgzadeh, Kenneth Tanabe, Cristina Ferrone, Andrew X Zhu, Karin Andersson, Michael Thiim, Onofrio Antonio Catalano, Avinash Kambadakone, Parsia A Vagefi, Motaz Qadan, Daniel Pratt, Nikroo Hashemi, Kathleen E Corey, Joseph Misdraji, Lipika Goyal, Jeffrey W Clark
Publikováno v:
The Oncologist. 28:341-350
Background Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are the leading causes of hepatocellular carcinoma (HCC) worldwide. Limited data exist on surgical outcomes for NAFLD/NASH-related HCC compared with other H
Publikováno v:
Journal of Clinical Oncology. 41:128-131